Vatalanib
CAS: 212141-54-3
Ref. 3D-MIA14154
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
- 1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-
- Cgp 79787
- N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine
- N-(4-Chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine
- Pynasunate
- Vatalinib
Vatalanib is a new anti-cancer drug that has been developed to inhibit the production of vascular endothelial growth factor (VEGF). It also inhibits cell factor (CF) and other biological properties. Vatalanib binds to the active site of the enzyme phosphatidylinositol 3-kinase, which is required for cell proliferation and survival. This binding leads to an increase in apoptosis, or programmed cell death, in cancer cells. Vatalanib has been shown to be effective against metastatic colorectal cancer and other solid tumours. The drug is not toxic to normal cells because it inhibits a protein that is required for activation of multiple pathways in these cells.
Propriedades químicas
Consulta técnica sobre: 3D-MIA14154 Vatalanib
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
